John Beadle, MD MBA
Non-Executive Director
During his career, John has founded and led several innovative biotech companies through spin-outs, fundraising and acquisitions. Most recently, he co-founded InnDura, a Boston based NK cell therapy company, where he was CEO. Prior to that, John co-founded the clinical-stage cancer gene therapy company PsiOxus (now Akamis in Boston) where he was CEO for 12 years. He also co-founded PowderMed, an Oxford UK based DNA vaccine company where he was Chief Medical Officer and Board Director through to the successful trade sale to Pfizer. His background is medical, holding roles of increasing seniority in clinical development and medical operations at GSK where he was VP of Global Medical operations. John is also currently on the Boards of Nykode, Vitarka, Scarlet, CamGene and Icosphere. John holds an MD from the University of Witwatersand and an MBA from the London Business School.
